1. Home
  2. WVE vs SSII Comparison

WVE vs SSII Comparison

Compare WVE & SSII Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Wave Life Sciences Ltd.

WVE

Wave Life Sciences Ltd.

BUY

Current Price

$3.45

Market Cap

744.8M

Sector

Health Care

ML Signal

BUY

Logo SS Innovations International Inc.

SSII

SS Innovations International Inc.

N/A

Current Price

$2.65

Market Cap

655.3M

Sector

N/A

ML Signal

N/A

Company Overview

Basic Information
Metric
WVE
SSII
Founded
2012
N/A
Country
United States
India
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
744.8M
655.3M
IPO Year
2015
2017

Fundamental Metrics

Financial Performance
Metric
WVE
SSII
Price
$3.45
$2.65
Analyst Decision
Strong Buy
Analyst Count
19
0
Target Price
★ $18.06
N/A
AVG Volume (30 Days)
★ 2.9M
65.8K
Earning Date
11-09-2026
10-27-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ 45.45
EPS
N/A
★ N/A
Revenue
$3,704,000.00
★ $42,484,747.00
Revenue This Year
$19.21
$40.29
Revenue Next Year
N/A
$27.85
P/E Ratio
N/A
★ N/A
Revenue Growth
★ 149.43
105.74
52 Week Low
$3.43
$2.62
52 Week High
$21.73
$10.00

Technical Indicators

Market Signals
Indicator
WVE
SSII
Relative Strength Index (RSI) 25.92 24.08
Support Level N/A N/A
Resistance Level $6.33 $4.16
Average True Range (ATR) 0.23 0.19
MACD -0.02 -0.03
Stochastic Oscillator 8.56 2.53

Price Performance

Historical Comparison
WVE
SSII

About WVE Wave Life Sciences Ltd.

WAVE Life Sciences Inc is a clinical-stage biotechnology company focused on unlocking the broad potential of RNA medicines also known as oligonucleotides, targeting ribonucleic acid (RNA), to transform human health. RNA medicines platform, PRISM, combines multiple modalities, chemistry innovation, and deep insights into human genetics to deliver scientific breakthroughs that treat both rare and prevalent disorders. Its toolkit of RNA-targeting modalities includes RNA editing, antisense silencing, and RNA interference, providing capabilities for designing and sustainably delivering candidates that optimally address disease biology. Its programs are for rare and prevalent diseases, including alpha-1 antitrypsin deficiency, obesity, Duchenne muscular dystrophy, and Huntington's disease.

About SSII SS Innovations International Inc.

SS Innovations International Inc is a commercial-stage surgical robotics company. It designs, manufactures, and markets a surgical robotic system called the SSi Mantra Surgical Robotic System (the SSi Mantra) intended for use in urology, general, gynecology, colorectal, gastroenterology, head and neck, thoracic, and cardiac surgeries. Additionally, the company offers a suite of stapling, energy, and core instrumentation for its surgical systems, under the brand name of SSi Mudra.

Share on Social Networks: